SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PTGX

Protagonist Therapeutics, Inc (PTGX)

NASDAQ: PTGX · Real-Time Price · USD
Healthcare · Biotechnology
139.88+1.45 (+1.04%)
 
Market cap
$9.05B
Analyst consensus
Insider Score
––Not scored
PTGX Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

PTGX Stock Insider Trading Activity

PTGX stock’s insider trading shows 13 sales on the open market for an estimated $52.99M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Ali Asif
CFO
Sell46,034$141.78$6.53M 43.8%59,003Sep 30, 2026— Form 4
Ali Asif
CFO
Option exercise28,438$23.42$666.02K 41.7%96,670Sep 30, 2026— Form 4
Ali Asif
CFO
Option exercise9,229$38.98$359.75K 15.6%68,232Sep 30, 2026— Form 4
Ali Asif
CFO
Sell12,595$141.77$1.79M 10.7%105,037Sep 30, 2026— Form 4
Ali Asif
CFO
Option exercise5,312$12.17$64.65K 4.7%117,632Sep 30, 2026— Form 4
Ali Asif
CFO
Option exercise15,650$19.19$300.32K 16.2%112,320Sep 30, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise7,278$21.58$157.06K 1.4%530,246Sep 10, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell7,278$144.10$1.05M 1.4%522,968Sep 10, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell63,548$146.18$9.29M 10.8%522,968Sep 9, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise63,548$21.58$1.37M 12.2%586,516Sep 9, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell54,174$145.87$7.90M 9.4%522,968Sep 8, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise54,174$21.58$1.17M 10.4%577,142Sep 8, 2026— Form 4
PATEL DINESH V PH D
CEO
Gift510—— 0.1%522,968Sep 3, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell34,239$148.52$5.09M 6.1%523,478Aug 11, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise34,239$21.58$738.88K 6.5%557,717Aug 11, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell65,761$149.11$9.81M 11.2%523,478Aug 10, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise65,761$21.58$1.42M 12.6%589,239Aug 10, 2026— Form 4
Waddill William D.
Director
Option exercise9,000$16.54$148.86K 115%16,825Jun 23, 2026— Form 4
Waddill William D.
Director
Sell9,000$117.94$1.06M 53.5%7,825Jun 23, 2026— Form 4
Waddill William D.
Director
Option exercise3,000$11.80$35.40K 38.3%10,825Jun 10, 2026— Form 4
Waddill William D.
Director
Sell9,000$107.68$969.12K 53.5%7,825Jun 10, 2026— Form 4
Waddill William D.
Director
Option exercise6,000$16.54$99.24K 55.4%16,825Jun 10, 2026— Form 4
Waddill William D.
Director
Sell9,000$99.64$896.76K 53.5%7,825May 29, 2026— Form 4
Waddill William D.
Director
Option exercise9,000$11.80$106.20K 115%16,825May 29, 2026— Form 4
PATEL DINESH V PH D
CEO
Option exercise75,000$21.58$1.62M 14.3%598,478May 12, 2026— Form 4
PATEL DINESH V PH D
CEO
Sell75,000$100.12$7.51M 12.5%523,478May 12, 2026— Form 4
Giraudo Bryan
Director
Sell5,130$100.00$513.00K 28.8%12,695May 8, 2026— Form 4
Giraudo Bryan
Director
Sell6,000$100.00$600.00K 100%0May 8, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Option exercise (M) — Exercise or conversion of an exempt derivative
  • Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Protagonist Therapeutics, Inc (PTGX) Insider Trading: Form 4 Buys & Sells | InsiderBuying.com